These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3118992)

  • 1. Response to the combined administration of interferons alpha and gamma after failure of single interferon therapy in chronic myelogenous leukaemia.
    Kloke O; Becher R; Niederle N
    Blut; 1987 Nov; 55(5):453-8. PubMed ID: 3118992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic myelogenous leukaemia: haematological remissions with alpha interferon.
    Talpaz M; McCredie K; Kantarjian H; Trujillo J; Keating M; Gutterman J
    Br J Haematol; 1986 Sep; 64(1):87-95. PubMed ID: 3463363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of clonal evolution in two chronic myelogenous leukaemia patients treated with leucocyte interferon.
    Talpaz M; Trujillo JM; Hittelman WN; Keating MJ; Gutterman JU
    Br J Haematol; 1985 Aug; 60(4):619-24. PubMed ID: 3861194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential therapy with recombinant interferons gamma and alpha in patients with unfavorable prognosis of chronic myelocytic leukemia: clinical responsiveness to recombinant IFN-alpha correlates with the degree of receptor down-regulation.
    Bartsch HH; Pfizenmaier K; Hanusch A; Scheurich P; Ucer U; Nagel GA
    Int J Cancer; 1989 Feb; 43(2):235-40. PubMed ID: 2521842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human interferon-alpha induced cytoreduction in chronic myelogenous leukemia. Results of a multicenter study.
    Werter M; de Witte R; Janssen J; de Pauw B; Haanen C
    Blut; 1988 May; 56(5):209-12. PubMed ID: 3285912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical investigation of interferons in the preleukemic state (CML and MDS)].
    Koyama S
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1191-7. PubMed ID: 3132893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical investigation of human alpha interferon in chronic myelogenous leukemia.
    Talpaz M; Kantarjian HM; McCredie KB; Keating MJ; Trujillo J; Gutterman J
    Blood; 1987 May; 69(5):1280-8. PubMed ID: 3471281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alfa-2c in chronic myelogenous leukemia (CML): hematologic, cytogenetic and molecular-genetic response of patients with chronic phase CML previously resistant to therapy with interferon gamma.
    Herrmann F; Jonas D; Helfrich SG; Lindemann A; Schleiermacher E; Mertelsmann R
    Blut; 1990 Oct; 61(4):226-31. PubMed ID: 2121299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia.
    Wandl UB; Kloke O; Nagel-Hiemke M; Moritz T; Becher R; Opalka B; Holtkamp W; Bartels H; Seeber S; Niederle N
    Br J Haematol; 1992 Aug; 81(4):516-9. PubMed ID: 1390238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Ph+ chronic myeloid leukemia by gamma interferon.
    Russo D; Fanin R; Zuffa E; Gallizia C; Grazia Michieli M; Damiani D; Testoni N; Pecile V; Visani G; Colombini R
    Blut; 1989 Jul; 59(1):15-20. PubMed ID: 2502210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.
    Talpaz M; Kantarjian HM; McCredie K; Trujillo JM; Keating MJ; Gutterman JU
    N Engl J Med; 1986 Apr; 314(17):1065-9. PubMed ID: 3457264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of chronic myelogenous leukemia with recombinant interferon-gamma.
    Kurzrock R; Talpaz M; Kantarjian H; Walters R; Saks S; Trujillo JM; Gutterman JU
    Blood; 1987 Oct; 70(4):943-7. PubMed ID: 3115339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].
    Niederle N; Doberauer C; Kloke O; Höffken K; Schmidt CG
    Klin Wochenschr; 1987 Jul; 65(14):706-12. PubMed ID: 3114551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interferon-alpha, but not interferon-gamma is effective therapy for essential thrombocythemia.
    Abegg-Werter MJ; Raemaekers JM; de Pauw BE; Haanen C
    Blut; 1990 Jan; 60(1):37-40. PubMed ID: 2105111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histopathological changes in bone marrow biopsies from patients with chronic myeloid leukaemia after treatment with recombinant alpha-interferon.
    Facchetti F; Tironi A; Marocolo D; Capucci A; Ruggeri G; Bellotti D; Rossi G
    Histopathology; 1997 Jul; 31(1):3-11. PubMed ID: 9253618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant gamma interferon on chronic myelogenous leukemia bone marrow progenitors.
    McGlave P; Mamus S; Vilen B; Dewald G
    Exp Hematol; 1987 May; 15(4):331-5. PubMed ID: 3106077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term treatment of chronic myelogenous leukemia with different interferons: results from three studies.
    Niederle N; Kloke O; Wandl UB; Becher R; Moritz T; Opalka B
    Leuk Lymphoma; 1993 Jan; 9(1-2):111-9. PubMed ID: 8477190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [alpha 2-interferon: preliminary treatment results in chronic myeloid leukemia].
    Niederle N; Kloke O; Doberauer C; Becher R; Beelen DW; Schmidt CG
    Dtsch Med Wochenschr; 1986 May; 111(20):767-72. PubMed ID: 3516621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferons combined with chemotherapy in the treatment of stage III-IV non-small cell lung cancer--a randomised study.
    Halme M; Maasilta PK; Pyrhönen SO; Mattson KV
    Eur J Cancer; 1994; 30A(1):11-5. PubMed ID: 8142151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.